Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

NCT04006041 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
Resectable Esophageal Cancer

Interventions

DRUG: Toripalimab
DRUG: Paclitaxel/cisplatin
RADIATION: Intensity-modulated radiotherapy
PROCEDURE: Esophagectomy

Sponsor

Jianhua Fu